Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes

Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more

A1025 a-MSH, amide

Summary: Melanocyte-stimulating hormones

≥166.5 mg/mL
A1019 Glucagon (19-29), human

Summary: Potent Ca2+/Mg2+-ATPase inhibitor

≥135.2 mg/mL
A1121 Melanocyte stimulating hormone release inhibiting factor

Summary: MSH release-inhibiting factor

≥59.1 mg/mL
A1024 LEP (116-130) (mouse)

Summary: An antiobesity hormone

≥156 mg/mL
A1013 Endomorphin-1

Summary: Agonist of μopioid receptors,highly potent and selective

≥30.55 mg/mL
A1134 Agouti-related Protein (AGRP) (25-82), human

Target: Melanocortin (MC) Receptors

Summary: Agouti-related peptide(25-82)

limited solubility in dmso

≥100 mg/mL
A1115 Peptide YY(3-36), PYY, human

Target: NPY Receptors

Summary: Y2R agonist

≥405 mg/mL

Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes

Product Catalog

Order Info

Customer service

Contact Us

Newsletter